What kind of results have people seen with Mounjaro®?

In clinical trials, Mounjaro® (tirzepatide) has delivered some of the most significant weight loss outcomes of any medication in its class. Participants in the SURMOUNT-1 trial lost an average of 15–21% of their body weight over 72 weeks, depending on dosage. Beyond weight reduction, many individuals also experienced improvements in blood sugar control, cholesterol, and other metabolic health markers. These results are clinically meaningful, as losing just 10% of body weight can reduce the risk of conditions like type 2 diabetes, high blood pressure, sleep apnea, and heart disease. When combined with lifestyle changes and structured support programs, Mounjaro® has the potential to deliver not only weight loss but also lasting improvements in overall health and quality of life.